LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Accueil・Liste d'Actions・Edwards Lifesciences Corp

Edwards Lifesciences Corp

Fermé

Secteur Soins de santé

66.76 1.26

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

66.52

Max

67.02

Chiffres clés
By Trading Economics
Revenu	14M 366M
Ventes	30M 1.6B
P/E Moyenne du Secteur	39.81 103.001
BPA	0.7
Marge bénéficiaire	22.472
Employés	19,800
EBITDA	-59M 417M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+20.64 upside

Dividendes
By Dow Jones
Prochains Résultats	23 oct. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-289M 42B
Ouverture précédente	65.5
Clôture précédente	66.76

Sentiment de l'Actualité

By Acuity

50%

287 / 365 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

64.7 / 68.66 Support & Résistance

Edwards Lifesciences Corp Graphique

Actualités Associées

15 juil. 2024, 13:57 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Buy Innovalve for $300 Million

3 sept. 2024, 20:38 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept. 2024, 20:37 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept. 2024, 20:36 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 juil. 2024, 09:02 UTC

Résultats

Actions en Tendance

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 juil. 2024, 08:40 UTC

Actualités

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 juil. 2024, 20:17 UTC

Résultats

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 juil. 2024, 20:15 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Sales $1.39B >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Net $366.3M >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q EPS 61c >EW

15 juil. 2024, 13:42 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Buy Innovalve for $300M

15 juil. 2024, 13:01 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 juil. 2024, 13:01 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 juil. 2024, 13:00 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 juil. 2024, 13:00 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences To Acquire Innovalve >EW

4 juin 2024, 17:26 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 juin 2024, 13:26 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 juin 2024, 12:25 UTC

Actualités

Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 juin 2024, 11:03 UTC

Actualités

Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 juin 2024, 10:40 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 juin 2024, 10:32 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 juin 2024, 10:31 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 juin 2024, 10:31 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 juin 2024, 10:30 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 juin 2024, 10:30 UTC

Acquisitions, Fusions, Rachats

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26 avr. 2024, 20:10 UTC

Résultats

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

25 avr. 2024, 21:05 UTC

Résultats

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

25 avr. 2024, 20:32 UTC

Résultats

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

Comparaison

Variation de prix

Edwards Lifesciences Corp prévision

Objectif de Prix

By TipRanks

20.64% hausse

Prévisions sur 12 Mois

Moyen 80.6 USD 20.64%

Haut 91 USD

Bas 70 USD

Basé sur 23 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

23 ratings

Achat

Maintien

Vente

Basé sur 23 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

64.7 / 68.66Support & Résistance

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

287 / 365Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

À Propos Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.